文献速递糖尿病肥胖与代谢综合征

肥胖与高血糖对餐后胰岛素介导与非胰岛素介导葡萄糖处置的影响

Effects of Obesity and Hyperglycemia on Postprandial Insulin-Mediated and Non-Insulin-Mediated Glucose Disposal.
PubMed 文献 · Diabetes Care · 2025-01-01

研究开发并验证了一种新的葡萄糖示踪模型结合口服葡萄糖耐量试验,在瘦型糖耐量正常者、肥胖伴胰岛素抵抗且糖耐量正常者、肥胖伴糖耐量受损者及肥胖伴2型糖尿病者中测定餐后总葡萄糖处置、胰岛素介导葡萄糖处置和非胰岛素介导葡萄糖处置。结果显示非胰岛素介导葡萄糖处置从瘦型到肥胖伴2型糖尿病逐步增加,在肥胖伴2型糖尿病中占总葡萄糖处置约80%。在肥胖伴2型糖尿病者中,强化生活方式治疗增加胰岛素介导葡萄糖处置并降低非胰岛素介导葡萄糖处置。

要点

  • 非胰岛素介导葡萄糖处置随糖代谢恶化逐步增加,在肥胖伴2型糖尿病中占总葡萄糖处置约80%。
  • 肥胖伴糖耐量受损和肥胖伴2型糖尿病者非胰岛素介导葡萄糖处置分别较肥胖伴糖耐量正常者高约2倍和约3倍。
  • 在肥胖伴2型糖尿病者中,强化生活方式治疗增加胰岛素介导葡萄糖处置并降低非胰岛素介导葡萄糖处置。

核心结论

  • 在胰岛素抵抗且胰岛素分泌不足的人群中,非胰岛素介导葡萄糖处置是餐后总葡萄糖处置的主要机制。

研究设计与样本

  • 开发并验证了一种新的葡萄糖示踪模型,结合口服葡萄糖耐量试验,在四组人群中测定餐后胰岛素介导葡萄糖处置、非胰岛素介导葡萄糖处置和总葡萄糖处置:瘦型糖耐量正常组、肥胖伴胰岛素抵抗且因高胰岛素血症糖耐量正常的Ob-NGT组、肥胖伴胰岛素抵抗且因高胰岛素血症不足糖耐量受损的Ob-IGT组、肥胖伴胰岛素抵抗且因明显胰岛素不足导致2型糖尿病的Ob-T2D组。
  • 另外评估了使体重下降约15%的强化生活方式治疗对肥胖伴2型糖尿病者胰岛素介导葡萄糖处置和非胰岛素介导葡萄糖处置的影响。

主要发现

  • 胰岛素介导葡萄糖处置从瘦型到Ob-NGT到Ob-IGT到Ob-T2D逐步降低,非胰岛素介导葡萄糖处置逐步增加。
  • 胰岛素介导葡萄糖处置占总葡萄糖处置的比例在瘦型、Ob-NGT、Ob-IGT和Ob-T2D分别约为70%、65%、50%和20%;非胰岛素介导葡萄糖处置占总葡萄糖处置的比例分别约为40%、35%、50%和80%。
  • 非胰岛素介导葡萄糖处置在Ob-IGT和Ob-T2D分别较Ob-NGT高约2倍和约3倍,但仅部分代偿Ob-IGT和Ob-T2D中明显受损的胰岛素介导葡萄糖处置。
  • 在肥胖伴2型糖尿病者中,强化生活方式治疗增加胰岛素介导葡萄糖处置并降低非胰岛素介导葡萄糖处置。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate total, insulin-mediated, and non-insulin-mediated glucose disposal (TGD, IMGD, and NIMGD) after ingesting glucose in people with obesity and different glycemic status. RESEARCH DESIGN AND METHODS: We developed and validated a new glucose tracer model in conjunction with an oral glucose tolerance test to determine IMGD, NIMGD, and TGD (sum of IMGD and NIMGD) after glucose ingestion in four groups of people: 1) lean with normal glucose tolerance (NGT), 2) obese with insulin resistance and NGT due to hyperinsulinemia (Ob-NGT group), 3) obese with insulin resistance and impaired glucose tolerance (IGT) due to inadequate hyperinsulinemia (Ob-IGT group), and 4) obese with insulin resistance and type 2 diabetes due to marked insulin insufficiency (Ob-T2D group). In addition, we evaluated the effect of intensive lifestyle therapy (ILT) that caused ∼15% weight loss on IMGD and NIMGD in people with obesity and type 2 diabetes (T2D). RESULTS: IMGD progressively decreased and NIMGD progressively increased from lean to Ob-NGT to Ob-IGT to Ob-T2D. IMGD accounted for about 70%, 65%, 50%, and 20% of TGD, and NIMGD accounted for ∼40%, 35%, 50%, and 80% of TGD in lean, Ob-NGT, Ob-IGT and Ob-T2D, respectively. Although NIMGD was approximately twofold and approximately threefold higher in Ob-IGT and Ob-T2D compared with Ob-NGT, NIMGD only partially compensated for markedly impaired IMGD in the Ob-IGT and Ob-T2D. ILT in people with obesity and T2D increased IMGD and decreased NIMGD. CONCLUSIONS: NIMGD is a major mechanism of postprandial TGD in people with insulin resistance and inadequate insulin secretion.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mittendorfer B, Patterson BW, Smith GI, et al. Effects of Obesity and Hyperglycemia on Postprandial Insulin-Mediated and Non-Insulin-Mediated Glucose Disposal. Diabetes Care. 2025. PMID: 39499792. doi:10.2337/dc24-1280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。